PERMANENT RULES
(Board of Osteopathic Medicine and Surgery)
Date of Adoption: June 23, 2001.
Purpose: Adopt rules for completion of prescriptive authority for Schedule II-IV drugs for advanced registered nurse practitioners. Rules outline qualifications, criteria for joint practice agreements, termination of joint practice agreements, the limit on dispensing, education and jurisdiction of the board/commissions.
Statutory Authority for Adoption: RCW 18.57.005 and 18.57.280.
Adopted under notice filed as WSR 01-10-128 on May 2, 2001.
Changes Other than Editing from Proposed to Adopted Version: Grammatical corrections made to WAC 246-853-222 Criteria for joint practice arrangement, subsections (1) and (2), to ensure they are correct sentences.
Number of Sections Adopted in Order to Comply with Federal Statute: New 0, Amended 0, Repealed 0; Federal Rules or Standards: New 0, Amended 0, Repealed 0; or Recently Enacted State Statutes: New 7, Amended 0, Repealed 0.
Number of Sections Adopted at Request of a Nongovernmental Entity: New 0, Amended 0, Repealed 0.
Number of Sections Adopted on the Agency's Own Initiative: New 0, Amended 0, Repealed 0.
Number of Sections Adopted in Order to Clarify, Streamline, or Reform Agency Procedures: New 0, Amended 0, Repealed 0.
Number of Sections Adopted Using Negotiated Rule Making:
New 7,
Amended 0,
Repealed 0;
Pilot Rule Making:
New 0,
Amended 0,
Repealed 0;
or Other Alternative Rule Making:
New 0,
Amended 0,
Repealed 0.
Effective Date of Rule:
Thirty-one days after filing.
July 3, 2001
Mark E. Hunt, D.O., Chair
Board of Osteopathic
Medicine and Surgery
OTS-4695.5
NEW SECTION
WAC 246-853-221
How do advanced registered nurse
practitioners qualify for prescriptive authority for Schedule II - IV drugs?
Applicants must:
(1) Hold a valid and unrestricted registered nurse license.
(2) Hold or be eligible for an advanced registered nurse practitioner license with authority for legend drugs and Schedule V drugs. (See also WAC 246-840-410.) As noted in RCW 18.79.250, each advanced registered nurse practitioner prescribes within his or her scope of practice for a particular license specialty.
(3) Have a joint practice arrangement that meets requirements of WAC 246-853-222 with a physician or physicians licensed under chapter 18.71 or 18.57 RCW who holds a license without restrictions related to prescribing scheduled drugs.
(4) Submit a completed application form for Schedule II - IV endorsement on a form provided by the department of health, nursing care quality assurance commission accompanied by a fee as specified in WAC 246-840-990.
[]
(1) The names of both the licensed advanced registered nurse practitioner and the licensed physician, both license numbers and both practice addresses;
(2) A written agreement that describes how collaboration will occur between the practitioners; and
(3) The description of the collaboration will vary according to the relationship between the advanced registered nurse practitioner and physician, but must include a description of:
(a) When the advanced registered nurse practitioner will consult with a physician;
(b) How consultation will occur (e.g., face-to-face, phone, fax, e-mail, etc.);
(c) How consultation will be documented.
(4) Joint practice arrangements may be made with more than one physician.
[]
(2) A notice of the joint practice arrangement shall be forwarded by the nursing care quality assurance commission to either the medical quality assurance commission or to the board of osteopathic medicine and surgery for review to assure the physician's license is unrestricted. The medical quality assurance commission or the board of osteopathic medicine and surgery will notify the nursing care quality assurance commission in the event a physician who has signed a joint practice arrangement, has a license with restrictions related to prescribing scheduled drugs.
(3) The advanced registered nurse practitioner can only begin prescribing Schedule II - IV drugs after his or her license endorsement has been issued and he or she has obtained the appropriate Drug Enforcement Administration registration.
[]
(2) The nursing care quality assurance commission will notify either the medical quality assurance commission or the board of osteopathic medicine and surgery that the joint practice arrangement has been terminated.
(3) A joint practice arrangement may be terminated as a result of disciplining action taken by a disciplining authority.
(4) In the event either the advanced registered nurse practitioner or the physician is disciplined, the disciplining authority for the other party will be notified that the joint practice arrangement no longer exists due to disciplinary action.
(5) If an advanced registered nurse practitioner has multiple approved joint practice arrangements and one is terminated, he or she may continue to prescribe Schedule II - IV drugs under the other joint practice arrangement(s).
[]
(2) The seventy-two-hour limit on dispensing does not apply to prescribing Schedule II - IV drugs.
[]
[]
[]